Articles in Business

Incyte's Jakafi Fails to Provide RELIEF in Polycythemia Vera - Analyst Blog

Incyte Corporation ( INCY ) announced disappointing top line results from the phase III RELIEF study (n=110) on Jakafi in the polycythemia vera (PV) indication. The RELIEF study is evaluating PV... Read >>

DICK'S Sporting Lays Off 400+ PGA Pro to Reduce Golf Exposure - Analyst Blog

Grappling with weaker demand for golf equipment for the past several quarters, the sporting goods retailer, DICK'S Sporting Goods Inc. ( DKS ) has finally decided to reduce its exposure in the... Read >>

St. Jude Medical Gets CE Mark for FlexAbility Catheter - Analyst Blog

Shares of St. Jude Medical Inc. ( STJ ) rose marginally following the announcement of receiving the Conformité Européenne (CE) Mark for its FlexAbility Ablation Catheter as well as its first use.... Read >>

Starbucks Brews Positive Earnings While Dunkin' Brands Melts - Analyst Blog

Starbucks ( SBUX ) reported earnings after the bell today.  Earnings came in ahead of the Zacks Consensus Earnings Estimate of $0.66 per share by posting Q3 earnings of $0.67 per share.  Revenues... Read >>

Shire, ArmaGen Ink Licensing Agreeement for AGT-182 - Analyst Blog

Shire ( SHPG ) recently entered into a worldwide licensing and collaboration agreement with privately held U.S. based biotechnology company, ArmaGen. The agreement is related to commercialization... Read >>

Nielsen Expands to 2 More Countries in South America - Analyst Blog

Information and measurement company, Nielsen N.V. ( NLSN ) recently announced its plans to expand its operating footprint to two more South American countries, Bolivia and Paraguay. The move will... Read >>

Ballard Power (BLDP) Named as Supplier for Fuel Cell Bus - Analyst Blog

A global leader in fuel cell technology Ballard Power Systems, Inc. ( BLDP ) has been selected by the heavy duty transit bus manufacturer New Flyer Industries to supply its first next generation... Read >>

UCB's Brivaracetam Positive in Phase III Epilepsy Study - Analyst Blog

UCB SA ( UCBJF ) announced positive top line results from a phase III study (n=768) on epilepsy candidate, brivaracetam. Brivaracetam achieved a statistically significant reduction in partial... Read >>

Is Xerox (XRX) Likely to Disappoint on Q2 Earnings? - Analyst Blog

Information technology services provider Xerox Corporation ( XRX ) is scheduled to report its second quarter 2014 results before the opening bell on Jul 25. In the last reported quarter, Xerox's... Read >>

Will TCF Financial (TCB) Miss Q2 Earnings Estimates? - Analyst Blog

TCF Financial Corporation ( TCB ) is scheduled to report its second quarter 2014 results on Jul 25. TCF Financial's first quarter 2014 earnings of 24 cents per share beat the Zacks Consensus... Read >>